Differential uptake of alkylating agents by normal and leukemic lymphocytes

Authors

  • Jerome I. Brody MD

    Corresponding author
    1. Department of Medicine, the Graduate Hospital of the University of Pennsylvania
    2. University of Pennsylvania School of Medicine
    • Medical College of Pennsylvania, 3300 Henry Avenue, Philadelphia, PA 19129
    Search for more papers by this author

Abstract

When 14C-labeled cyclophosphamide and nitrogen mustard were incubated separately with normal lymphocytes and lymphocytes from patients with chronic lymphocytic leukemia, the amount of radioactivity associated with the normal cells far exceeded that detected on the leukemic lymphocytes. This comparative diminution may be analogous to the impaired PHA response and excess surface immunoglobulin which serve as identifying markers of the malignant B cell. Cytotoxicity and neuraminidase experiments indicated that drug uptake by lymphocytes is not capricious and may occur in an optimum, predetermined fashion. Although surface uptake and therapeutic response are not necessarily directly interrelated, initial peripheral contact with an antineoplastic agent may be an essential step which modifies tumor sensitivity or resistance. Cancer 36:1959–1965, 1975

Ancillary